Abstract
Purpose
To investigate staging accuracy of multidetector CT (MDCT) for pancreatic neuroendocrine tumour (PNET) and diagnostic performance for differentiation of PNET from pancreatic adenocarcinoma.
Material and methods
We included 109 patients with surgically proven PNET (NETG1 = 66, NETG2 = 31, NEC = 12) who underwent MDCT. Two reviewers assessed stage and presence of predefined CT findings. We analysed the relationship between CT findings and tumour grade. Using PNETs with uncommon findings, we also estimated the possibility of PNET or adenocarcinoma.
Results
Accuracy for T stage was 85–88 % and N-metastasis was 83–89 %. Common findings included well circumscribed, homogeneously enhanced, hypervascular mass, common in lower grade tumours (p < 0.05). Uncommon findings included ill-defined, heterogeneously enhanced, hypovascular mass and duct dilation, common in higher grade tumours (p < 0.05). Using 31 PNETs with uncommon findings, diagnostic performance for differentiation from adenocarcinoma was 0.760–0.806. Duct dilatation was an independent predictor for adenocarcinoma (Exp(B) = 4.569). PNETs with uncommon findings were associated with significantly worse survival versus PNET with common findings (62.7 vs. 95.7 months, p < 0.001).
Conclusion
MDCT is useful for preoperative evaluation of PNET; it not only accurately depicts the tumour stage but also prediction of tumour grade, because uncommon findings were more common in higher grade tumours.
Key Points
• CT accurately depicts the T stage and node metastasis of PNET.
• Uncommon findings were more common in higher grade tumours.
• CT information may be beneficial for optimal therapeutic planning.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-015-3941-7/MediaObjects/330_2015_3941_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-015-3941-7/MediaObjects/330_2015_3941_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-015-3941-7/MediaObjects/330_2015_3941_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-015-3941-7/MediaObjects/330_2015_3941_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-015-3941-7/MediaObjects/330_2015_3941_Fig5_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00330-015-3941-7/MediaObjects/330_2015_3941_Fig6_HTML.gif)
Similar content being viewed by others
References
Ehehalt F, Saeger HD, Schmidt CM, Grützmann R (2009) Neuroendocrine tumors of the pancreas. Oncologist 14:456–467
Owen N, Sohaib S, Peppercorn P et al (2001) MRI of pancreatic neuroendocrine tumours. Br J Radiol 74:968–973
Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours of the digestive system. World Health Organization
Ekeblad S, Skogseid B, Dunder K, Öberg K, Eriksson B (2008) Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res 14:7798–7803
Rindi G, Klöppel G, Alhman H et al (2006) TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395–401
Sellner F, Thalhammer S, Stättner S, Karner J, Klimpfinger M (2011) TNM stage and grade in predicting the prognosis of operated, non‐functioning neuroendocrine carcinoma of the pancreas—a single‐institution experience. J Surg Oncol 104:17–21
Poultsides GA, Huang LC, Chen Y et al (2012) Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis. Ann Surg Oncol 19:2295–2303
Procacci C, Carbognin G, Accordini S et al (2001) Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization. Eur Radiol 11:1175–1183
Rha SE, Jung SE, Lee KH, Ku YM, Byun JY, Lee JM (2007) CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification. Eur J Radiol 62:371–377
Rodallec M, Vilgrain V, Zins M, Couvelard A, Ruszniewski P, Menu Y (2002) Helical CT of pancreatic endocrine tumors. J Comput Assist Tomogr 26:728–733
d'Assignies G, Couvelard A, Bahrami S et al (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors1. Radiology 250:407–416
Rodallec M, Vilgrain V, Couvelard A et al (2006) Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 6:77–85
Tatsumoto S, Kodama Y, Sakurai Y, Shinohara T, Katanuma A, Maguchi H (2013) Pancreatic neuroendocrine neoplasm: correlation between computed tomography enhancement patterns and prognostic factors of surgical and endoscopic ultrasound-guided fine-needle aspiration biopsy specimens. Abdom Imaging 38:358–366
Worhunsky DJ, Krampitz GW, Poullos PD et al (2014) Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness. HPB 16:304–311
Edge SB, Byrd D, Compton C, Fritz A, Greene FL, Trotti A (2010) AJCC cancer staging manual, 7th edn. Springer, New York, pp 285–296
Kim DW, Kim HJ, Kim KW et al (2014) Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour. Eur Radiol 25(5):1375–1383
Tummala P, Rao S, Agarwal B (2013) Differential diagnosis of focal non-cystic pancreatic lesions with and without proximal dilation of pancreatic duct noted on CT scan. Clin Transl Gastroenterol 4:e42
Fischer L, Kleeff J, Esposito I et al (2008) Clinical outcome and long‐term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 95:627–635
Martin RC, Kooby DA, Weber SM et al (2011) Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system. J Gastrointest Surg 15:175–183
Hammerstingl RM, Vogl TJ (2005) Abdominal MDCT: protocols and contrast considerations. Eur Radiol Suppl 15:e78–e90
Marin D, Nelson RC, Barnhart H et al (2010) Detection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase: Effect of a low-tube-voltage, high-tube-current CT technique—preliminary results 1. Radiology 256:450–459
Acknowledgments
We thank Bonnie Hami, South Euclid, Ohio, and Jeehyun Kim, Berkeley, California, for editorial assistance in the preparation of this manuscript.
The scientific guarantor of this publication is Joon Koo Han, M.D. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding, and have no conflicts of interest to declare. Young Jae Kim M.D. has significant statistical expertise and no complex statistical methods were necessary for this paper. Institutional Review Board approval was obtained (IRB No. 1304-052-480). Written informed consent was waived by the Institutional Review Board. No study subjects or cohorts have been previously reported. Methodology: retrospective, diagnostic study, performed at one institution.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, J.H., Eun, H.W., Kim, Y.J. et al. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma. Eur Radiol 26, 1338–1347 (2016). https://doi.org/10.1007/s00330-015-3941-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-015-3941-7